TARIS Biomedical Launches with $15 Million in Funding to Develop Innovative Drug-Device Therapies
Minimally Invasive Drug-Device Convergence Technology Developed by Leading MIT Scientists
Lead Program In Area Of High Unmet Medical Need
LEXINGTON, Mass., June 24, 2009– TARIS Biomedical, a specialty pharmaceutical company pioneering the field of drug-device convergence for targeted therapies, launched today and announced it has secured $15 million in Series A financing. Leading venture capital firms [...]
